EUVIMEDEUVIMED entdecken
Crossref

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism

Yingjia Yao, Yunhan Zhang, Zexu Li, Zhisong Chen, Xiaofeng Wang, Zihan Li, Li Yu, Xiaolong Cheng, Wei Li, Wen-Jie Jiang, Hua-Jun Wu, Zezhong Feng und 2 weitere

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.07.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Yingjia Yao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang, …. Hauptthemen laut MEDLINE: COVID-19, Deep Learning. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Overseas Expertise Introduction Project for Discipline Innovation, Fundamental Research Funds for the Central Universities, Science and Technology Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent outbreak of Corona Virus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a severe threat to the global public health and economy, however, effective drugs to treat COVID-19 are still lacking. Here, we employ a deep learning-based drug repositioning strategy to systematically screen potential anti-SARS-CoV-2 drug candidates that target the cell entry mechanism of SARS-CoV-2 virus from 2635 FDA-approved drugs and 1062 active ingredients from Traditional Chinese Medicine herbs. In silico molecular docking analysis validates the interactions between the top compounds and host receptors or viral spike proteins. Using a SARS-CoV-2 pseudovirus system, we further identify several drug candidates including Fostamatinib, Linagliptin, Lysergol and Sophoridine that can effectively block the cell entry of SARS-CoV-2 variants into human lung cells even at a nanomolar scale. These efforts not only illuminate the feasibility of applying deep learning-based drug repositioning for antiviral agents by targeting a specified mechanism, but also provide a valuable resource of promising drug candidates or lead compounds to treat COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Deep LearningHumansSARS-CoV-2Drug RepositioningMolecular Docking SimulationVirus InternalizationAntiviral Agents

Stichwörter der Autor:innen

COVID-19DrugSARS-CoV-2Target

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang, 110819, China; National Frontiers Science Center for Industrial Intell…
  • Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang, 110819, China.
  • Center for Genetic Medicine Research, Children's National Hospital, 111 Michigan Ave NW, Washington, DC, 20010, USA; Department of Genomics and Precision Medicine, George Washington University, 111 Michigan Ave NW, Wash…
  • Peking University Cancer Hospital and Institute, Beijing, 100142, China.
  • Peking University Cancer Hospital and Institute, Beijing, 100142, China; Center for Precision Medicine Multi-Omics Research, School of Basic Medical Sciences, Peking University Health Science Center, Peking University,…

Förderung

  • Overseas Expertise Introduction Project for Discipline Innovation
  • Fundamental Research Funds for the Central Universities
  • Science and Technology Program of Hunan Province
  • Higher Education Discipline Innovation Project

Zitieren

APA

Yao, Y., Zhang, Y., Li, Z., Chen, Z., Wang, X., Li, Z., Yu, L., Cheng, X., Li, W., Jiang, W. J., Wu, H. J., Feng, Z., Sun, J., & Fei, T. (2023). A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.07.018

Vancouver

Yao Y, Zhang Y, Li Z, Chen Z, Wang X, Li Z, et al. A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.07.018

BibTeX
@article{Yao2023,
  author = {Yao, Yingjia and Zhang, Yunhan and Li, Zexu and Chen, Zhisong and Wang, Xiaofeng and Li, Zihan and Yu, Li and Cheng, Xiaolong and Li, Wei and Jiang, Wen-Jie and Wu, Hua-Jun and Feng, Zezhong and Sun, Jinfu and Fei, Teng},
  title = {A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.07.018}
}
Kostenlos starten →